NE-100
NE-100 is a selective sigma-1 receptor antagonist, with a reported binding affinity of Ki = 1.03 ± 0.01 nM, and more than 205 times selectivity over the sigma-2 receptor. It has been used in scientific research.
Pharmacology[edit | edit source]
NE-100 is a selective sigma-1 receptor antagonist. The sigma-1 receptor is a chaperone protein at the endoplasmic reticulum (ER) that modulates calcium signaling through the IP3 receptor. In the context of neurobiology, sigma-1 receptor agonists have been shown to promote neuroplasticity, while antagonists have been shown to block this activity.
Chemistry[edit | edit source]
NE-100 is a synthetic compound of the sigma receptor antagonist class. It is structurally related to other sigma receptor antagonists such as BD-1008 and BD-1047, but is reported to have greater selectivity for the sigma-1 subtype.
Research[edit | edit source]
NE-100 has been used in scientific research to study the role of sigma-1 receptors in various processes including neuroplasticity, pain perception, and the action of certain drugs of abuse. It has also been used to investigate the potential therapeutic applications of sigma-1 receptor antagonists in conditions such as depression, anxiety, and schizophrenia.
See also[edit | edit source]
References[edit | edit source]
NE-100 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD